Objectives. Development of nanoparticles (NPs) for biomedical applications, including medical imaging and drug delivery, is currently undergoing a dramatic expansion. Diverse effects of different type NPs relating to mammalian reproductive tissues have been demonstrated. Th e objective of this study was to explore the in vitro effects of polymeric nanoparticle poly(ethylene glycol)-blockpolylactide methyl ether (PEG-b-PLA NPs) on functional state and viability of ovarian granulosa cells (GCs), which play an important role in maintaining ovarian function and female fertility.
Methods. The GCs isolated from porcine ovarian follicles were incubated with the different concentrations of PEG-b-PLA NPs (PEG average Mn=350 g/mol and PLA average Mn=1000 g/mol; 0.2-100 μg/ml) or poly(ethylene glycol) with an average molecular weight of 300 (PEG-300; 0.2- 40 mg/ml) in the presence or absence of stimulators, follicle-stimulating hormone (FSH; 1 μg/ml), androstenedione (100 nM), forskolin (10 μM) or 8Br-cAMP (100 μM), for different time periods (24, 48, 72 h). At the end of the incubation, progesterone and estradiol levels produced by GCs were measured in the culture media by radioimmunoassay. Th e viability of GCs was determined by the method using a colorimetric assay with MTT.
Results. Treatment of GCs with PEG-b-PLA NPs induced a significant decrease in basal as well as FSH-stimulated progesterone secretion above the concentration of 20 and 4 μg/ml, respectively. Moreover, PEG-b-PLA NPs reduced forskolin-stimulated, but not cAMP-stimulated progesterone production by GCs. A dose-dependent inhibition of androstenedione-stimulated estradiol release by GCs was found by the action of PEG-b-PLA NPs. Incubation of GCs with PEG-300 significantly inhibited basal as well as FSH-stimulated progesterone secretion above the concentration of 40 mg/ml. PEG-b-PLA NPs and PEG-300 significantly reduced the viability of GCs at the highest tested concentrations (100 μg/ml and 40 mg/ml, respectively).
Conclusions. The obtained results indicate that polymeric NPs PEG-b-PLA might induce alterations in steroid hormone production by ovarian GCs and thereby could modify reproductive functions.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Campagnolo L Massimiani M Magrini A Camaioni A Pietroiusti A. Physico-chemical properties mediating reproductive and developmental toxicity of engineered nanomaterials. Curr Med Chem 19 4488-4494 2012.
De Jong WH Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 3 133-149 2008.
Du JZ Tang LY Song WJ Shi Y Wang J. Evaluation of polymeric micelles from brush polymer with poly(ε- caprolactone)-b-poly(ethyleneglycol) side chains as drug carrier. Biomacromolecules 10 2169-2174 2009.
El-Ansary A Al-Daihan S. On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol 2009 754810 2009.
Ema M Kobayashi N Naya M Hanai S Nakanishi J. Reproductive and developmental toxicity studies of manufactured nanomaterials. Reprod Tox 30 343-352 2010.
Ferrandina G Corrado G Licameli A Lorusso D Fuoco G Pisconti S Scambia G. Pegylated liposomal doxorubicin in the management of ovarian cancer. Th er Clin Risk Manag 6 463-483 2010.
Gajdova M Jakubovsky J Valky J. Delayed eff ects of neonatal exposure to Tween 80 on female reproductive organs in rats. Food Chem Toxicol 31183-190 1993.
Iavicoli I Fontana L Leso V Bergamaschi A. Th e eff ects of nanomaterials as endocrine disruptors. Int J Mol Sci 14 16732-16801 2013.
Jamnongjit M Hammes SR. Ovarian steroids: the good the bad and the signals that raise them. Cell Cycle 5 1178-1183 2006.
Kedar U Phutane P Shidhaye S Kadam V Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6 714-729 2010.
Kolena J Scsukova S Jezova M Furdova J Tatara M Jasem P. Eff ect of phospholipids on the reconstitution and thermal stability of delipidated rat ovarian luteinizing hormone/human chorionic gonadotropin receptors in proteoliposomes. Mol Cell Endocrinol 113 53-60 1995.
Lu X Kong X Lobie PE Chen Ch Zhu T. Nanotoxicity: a growing need for study in the endocrine system. Small 9 1654-1671 2013.
Moritz M Gezske-Moritz M. Recent developments in the application of polymeric nanoparticles as drug carriers. Adv Clin Exp Med 24 749-758 2015.
Oberdoster G. Safety assessment for nanotechnology and nanomedicine: concept of nanotoxicology. J Intern Med 267 89-105 2009.
Patel T Zhou J Piepmeier JM Saltzman WM. Polymeric nanoparticles for drug delivery to the central nervous system. Adv Drug Deliv Rev 163 93-99 2012.
Pelham RW Nix LC Chavira RE Cleveland MVB Stetson P. Clinical trial: si ngle- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in young and elderly subjects. Aliment Pharmacol Th er 25 256-265 2008.
Pottler M Staicu A Zaloga J Unterweger H Weigel B Schreiber E Hofmann S Wiest I Jeschke U Alexiou Ch Janko Ch. Genotoxicity of superparamagnetic iron oxide nanoparticles in granulosa cells. Int J Mol Sci 16 26280-26290 2015.
Rollerova E Scsukova S Jurcovicova J Mlynarcikova A Szabova E Kovriznych J Zeljenkova D. Polymeric nanoparticles - targeted drug delivery systems for treatment of CNS disorders and their possible endocrine disrupting activities. Endocr Regul 45 49-60 2011.
Rollerova E Jurcovicova J Mlynarcikova A Sadlonova I Bilanicova D Wsolova L Kiss A Kovriznych J Kronek J Ciampor F Vavra I Scsukova S. Delayed adverse eff ects of neonatal exposure to polymeric nanoparticle poly(ethylene glycol)-block-polylactide methyl ether on hypothalamic-pituitary-ovarian axis development and function in Wistar rats. Reprod Toxicol 57 165-175 2015a.
Rollerova E Tulinska J Liskova A Kuricova M Kovriznych J Mlynarcikova A Kiss A Scsukova S. Titanium dioxide nanoparticles: some aspects of toxicity/focus on the development. Endocr Regul 49 97-112 2015b.
Scsukova S Mlynarcikova A Kiss A Rollerova E. Eff ect of polymeric nanoparticle poly(ethylene glycol)-blockpoly(lactic acid) (PEG-b-PLA) on in vitro luteinizing hormone release from anterior pituitary cells of infantile and adult female rats. Neuro Endocrinol Lett 36 (Suppl 1) 88-94 2015.
Semete B Booysen L Lemmer Y Kalombo L Katata L Verschoor J Swai HS. In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine 6 662-671 2010.
Taylor U Barchanski A Kues W Barcikowski S Rath D. Impact of metal nanoparticles on germ cell viability and functionality. Reprod Domest Anim 47(Suppl. 4) 359-368 2012.
Sharma A Madhunapantula SV Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol 8 47-69 2012.
Shen S Du XJ Liu J Sun R Zhu YH Wang J. Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy. J Control Release 208 14-24 2015.
Shin HC Alani AWG Rao DA Rockich NC Kwon GS. Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J Control Release 140 293-300 2009.
Shin HC Cho H Lai TC Kozak KR Kolesar JM Kwon GS. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)- block-poly(DL-lactic acid) micelles carrying paclitaxel 17-allylamino-17-demethoxygel danamycin and rapamycin. J Control Release 163 93-99 2012.
Tosi G Constantino L Ruozi B Forni F Vandelli MA. Polymeric nanoparticles for the drug delivery to central nervous system. Expert Opin Drug Deliv 5 155-174 2008.
Zhang WD Zhao Y Zhang HF Wang SK Hao ZH Liu J Yuan YQ Zhang PF Yang HD Shen W Li L. Alteration of gene expression by zinc oxide nanoparticles or zinc sulfate in vivo and comparison with in vitro data: A harmonious case. Th eriogenology 86 850-861 2016.
Wang J Liu Y Jiao F Lao F Li W Gu Y Li Y Ge C Zhou G Li B Zhao Y Chai Z Chen C. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology 254 82-90 2008.
Wang H Rempel GL. Introduction of polymer nanoparticles for drug delivery applications. J Nanotechnol Nanomed Nanobiotechnol 2 008 2015.
Wang N Wang Z Nie S Song L He T Yang S Yang X Yi C Wu Q Gong C. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo. Int J Nanomedicine 12 1499-1514 2017.
Xiao RZ Zeng ZW Zhou GL Wang JJ Li FZ Wang AM. Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine 5 1057-1065 2010.
Xiao L Xiong X Sun X Zhu Y Yang H Chen H Gan L Xu H Yang X. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 32 5148-5157 2011.